BioCentury | May 5, 2014
Company News

ALK-Abello, Eddingpharm sales and marketing update

...Eddingpharm received exclusive rights to market ALK-Abello's house mite allergy products Soluprick SQ and Alutard SQ in...
...met. Soluprick SQ is a skin prick test to diagnose house dust mite allergy, and Alutard SQ...
BioCentury | Mar 17, 2014
Finance

Circassia raises expectations

...ALK-Abello markets its Grazax tablet-based sublingual allergen immunotherapy to treat grass pollen allergy in Europe. Alutard SQ...
BioCentury | Aug 20, 2007
Clinical News

Alutard SQ inflammation data

...symptom scores remained significantly lower vs. control (p<0.05). ALK Abello A/S (CSE:ALK-B), Horsholm, Denmark Product: Alutard SQ...
BioCentury | Mar 17, 2003
Clinical News

Alutard SQ: Phase III data; Marketed outside the U.S. to treat pollen, dust mite, animal hair, insect sting and grass allergies

...of Allergy, Asthma and Immunology meeting in Denver. ALK Abello A/S , Horsholm, Denmark Product: Alutard SQ...
BioCentury | Aug 16, 1999
Clinical News

Alutard SQ: Marketed

...allergy immunotherapy produces a persistent alteration in immunologic reactivity. ALK Abello A/S, Horsholm, Denmark Product: Alutard SQ...
Items per page:
1 - 5 of 5